NEW YORK (GenomeWeb) – Epigenomics today reported that its first quarter revenues dropped 10 percent year over year on lower product revenues.

The German molecular diagnostics firm reported revenues of €367,000 ($412,920) versus revenues of €407,000 for the first quarter of 2015. The company said that its product revenues declined 21 percent year over year to €169,000, but added in a statement that it has received initial product orders from China, which it believes will lead to higher revenue in the second half of the year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.